The association between the genetic polymorphisms of LMP2/LMP7 and the outcomes of HCV infection among drug users

Journal of Biomedical Research

Volumn 24, Issue 5, 2010, Pages 374-380

  Cui, Qian ^a   Zhang, Yongxiang ^b   Su, Jing ^a   Shi, Chao ^a   Lei, Na ^a   Ding, Keqin ^a   Li, Jun ^b   Yu, Rongbin ^a   Wang, Lu ^c   Wang, Ning ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Hepatitis C virus; Infection; LMP gene; Outcome; Polymorphism

Indexed keywords

ARGININE; GENOMIC DNA; GLUTAMIC ACID; GLUTAMINE; HISTIDINE; LYSINE;

ADULT; ALLELE; ARTICLE; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LEUKOCYTE; LMP 2 GENE; LMP 7 GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 79952725220     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1674-8301(10)60050-4     Document Type: Article

References (21)

1. Dai ZC, Qi GM. Seroepidemiological study of viral hepatitis in China. Beijing: Scientific and Technical Documents Publishing House, 1997:60-71.
2. Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS 2009;20:399-405.
3. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36(5 Suppl 1):35-46.
4. Thio CL. Host genetic factors and antiviral immune responses to hepatitis C virus. Clin Liver Dis 2008;12:713-26.
5. Sun J, Li K, Shata MT, Chan TS. The immunologic basis for hepatitis C infection. Curr Opin Gastroenterol 2004;20:598-602.
6. Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, et al. Cytotoxic Tlymphocyte response and viral load in hepatitis C virus infection. Hepatology 1997;25:705-12.
7. York IA, Rock KL. Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 1996;14:369-96.
8. Driscol J, Brown MG, Finley D, Monaco JJ. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 1993;365:262-4.
9. Vargas-Alarcón G, Gamboa R, Zuñiga J, Fragoso JM, Hernández-Pacheco G, Londoño J, et al. Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 2004;65:1437-42.
10. Prahalad S, Kingsbury DJ, Griffin TA, Cooper BL, Glass DN, Maksymowych WP, et al. Polymorphism in the MHC-encoded LMP7 gene: Association with JRA without functional significance for immunoproteasome assembly. J Rheumatol 2001;28:2320-5.
11. Cao B, Tian X, Li Y, Jiang P, Ning T, Xing H, et al. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 2005;26:1280-4.
12. Dai Y, Ning T, Li K, Qi SX, Jiang MW, Chai QB, et al. Association between LMP2/LMP7 gene polymorphism and the infection of hepatitis B virus. Beijing Da Xue Xue Bao(in Chinese) 2005;37:508-12.
13. Xu C, Qi S, Gao L, Cui H, Liu M, Yang H, et al. Genetic polymorphisms of LMP/TAP gene and hepatitis B virus infection risk in the Chinese population. J Clin Immunol 2007;27:534-41.
14. Taniuchi S, Masuda M, Teraguchi M, Ikemoto Y, Komiyama Y, Takahashi H, et al. Polymorphism of Fc gamma RIIa may affect the efficacy of gammaglobulin therapy in Kawasaki disease. J Clin Immunol 2005;25:309-13.
15. Van Belzen MJ, Mulder CJ, Zhernakova A, Pearson PL, Houwen RH, Wijmenga C. CTLA4 + 49A/G and CT60 polymorphisms in Dutch coeliac disease patients. Eur J Hum Genet 2004;12:782-5.
16. Sun J, Li K, Shata MT, Chan TS. The immunologic basis for hepatitis C infection. Curr Opin Gastroenterol 2004;20:598-602.
17. Gaczynska M, Goldberg AL, Tanaka K, Hendil KB, Rock KL. Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-gamma-induced subunits LMP2 and LMP7. J Biol Chem 1996;271:17275-80.
18. Sugimoto Y, Kuzushita N, Takehara T, Kanto T, Tatsumi T, Miyagi T, et al. A single nucleotide polymorphism of the low molecular mass polypeptide 7 gene influences the interferon response in patients with chronic hepatitis C. J Viral Hepat 2002;9:377-84.
19. Lee HJ, Ha SJ, Han H, Kim JW. Distribution of HLA-A, B alleles and polymorphisms of TAP and LMP genes in Korean patients with atopic dermatitis. Clin Exp Allergy 2001;31:1867-74.
20. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-67.
21. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and enviromnental factors. JAMA 2000;284:450-6.